Mochida Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mochida Pharmaceutical Company Limited with three other
companies in this sector in Japan:
KYORIN Holdings, Incorporation
sales of 110.64 billion Japanese Yen [US$981.38 million]
of which 95%
was Pharmaceutical Business),
Kaken Pharmaceutical Co Ltd
(98.43 billion Japanese Yen [US$873.07 million]
of which 98%
was Pharmaceutical), and
Nippon Shinyaku Co Ltd
(101.45 billion Japanese Yen [US$899.84 million]
of which 86%
was Pharmaceutical Products).
Mochida Pharmaceutical Company Limited reported sales of ¥106.76 billion (US$946.97 million)
March of 2018.
increase of 9.7%
versus 2017, when the company's sales were ¥97.35 billion.
This was the third consecutive year of growth at Mochida Pharmaceutical Company Limited.